{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:24:43Z","timestamp":1790216683353,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier","isbn-type":[{"value":"9780443414435","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.mcb.2025.02.021","type":"book-chapter","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:25:44Z","timestamp":1742228744000},"page":"135-172","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic analysis in cancer research"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.mcb.2025.02.021_bib1","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1128\/MCB.23.23.8429-8439.2003","article-title":"GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer","volume":"23","author":"Akiyama","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3816\/CGC.2007.n.029","article-title":"Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy","volume":"5","author":"Amato","year":"2007","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/07357907.2012.675381","article-title":"MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma","volume":"30","author":"Amato","year":"2012","journal-title":"Cancer Investigation"},{"key":"10.1016\/bs.mcb.2025.02.021_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1947601910365081","article-title":"DNA demethylating antineoplastic strategies: A comparative point of view","volume":"1","author":"Amatori","year":"2010","journal-title":"Genes & Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/ncb1403","article-title":"Chromatin signatures of pluripotent cell lines","volume":"8","author":"Azuara","year":"2006","journal-title":"Nature Cell Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-resolution profiling of histone methylations in the human genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","article-title":"The mammalian epigenome","volume":"128","author":"Bernstein","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes & Development"},{"key":"10.1016\/bs.mcb.2025.02.021_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetic in cancer: Fundamentals and beyond","author":"Biswas","year":"2017","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.02.043","article-title":"Resminostat in combination with sorafenib as second-line therapy of advanced hepatocellular carcinoma\u2014the shelter study","author":"Bitzer","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib13","first-page":"4682","article-title":"Ras oncogenes in human cancer: A review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib14","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/0008-5472.CAN-04-2957","article-title":"Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases","volume":"65","author":"Brueckner","year":"2005","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.mcb.2025.02.021_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-015-0095-z","article-title":"Epigenetic activities of flavonoids in the prevention and treatment of cancer","volume":"7","author":"Busch","year":"2015","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib16","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevEukarGeneExpr.v6.i1.50","article-title":"Drugs that target gene expression: An overview","volume":"6","author":"Cavalieri","year":"1996","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"key":"10.1016\/bs.mcb.2025.02.021_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: Patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib18","doi-asserted-by":"crossref","first-page":"14510","DOI":"10.1074\/jbc.M113.458737","article-title":"Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression","volume":"288","author":"Chen","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14427","article-title":"Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB\u2013IVAmycosis fungoides\/S\u00e9zary syndrome","author":"Child","year":"2016","journal-title":"British Journal of Dermatology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib20","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1021\/jm3004009","article-title":"Fluorocyclopentenyl-cytosine with broad spectrum and potent antitumor activity","volume":"55","author":"Choi","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib21","doi-asserted-by":"crossref","first-page":"T19","DOI":"10.1530\/ERC-14-0185","article-title":"Histone H2B monoubiquitination: Roles to play in human malignancy","volume":"22","author":"Cole","year":"2015","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib22","article-title":"Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment","volume":"67","author":"Constantinides","year":"1977","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2025.02.021_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2025.02.021_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.23849","article-title":"Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer","volume":"124","author":"Daskalos","year":"2009","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib26","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/onc.2011.383","article-title":"Dynamic epigenetic regulation of themicroRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis","volume":"31","author":"Davalos","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2025.02.021_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1535-6108(03)00051-5","article-title":"MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP","volume":"3","author":"Deguchi","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: Azacitidine and decitabine","volume":"18","author":"Derissen","year":"2013","journal-title":"The Oncologist"},{"key":"10.1016\/bs.mcb.2025.02.021_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1517\/17425255.2014.947263","article-title":"Hydralazine\u2013valproate: A repositioned drug combination for the epigenetic therapy of cancer","volume":"10","author":"Due\u00f1as-Gonzalez","year":"2014","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib30","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/ng1909","article-title":"DNA methylation profiling of human chromosomes 6, 20 and 22","volume":"38","author":"Eckhardt","year":"2006","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-1-2","article-title":"Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF)","volume":"1","author":"Ehrlich","year":"2006","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/bs.mcb.2025.02.021_bib33","series-title":"Epigenetic alterations in oncogenesis","first-page":"31","article-title":"DNA hypomethylation and hemimethylation in cancer","author":"Ehrlich","year":"2013"},{"key":"10.1016\/bs.mcb.2025.02.021_bib34","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2025.02.021_bib35","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/sj.onc.1202178","article-title":"MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas","volume":"17","author":"Esteller","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2025.02.021_bib36","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.0810362106","article-title":"Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells","volume":"106","author":"Esteve","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.021_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1078-0432.CCR-15-0624","article-title":"A phase I\/II multicenter, open-label study of the oral histone deacetylase inhibitor abexinostat in relapsed\/refractory lymphoma","volume":"22","author":"Evens","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib38","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.021_bib39","doi-asserted-by":"crossref","DOI":"10.1517\/13543776.2012.729579","article-title":"DNA methyltransferase inhibitors in cancer: A chemical and therapeutic patent overview and selected clinical studies","author":"Fahy","year":"2012","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/bs.mcb.2025.02.021_bib40","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1093\/jn\/137.1.223S","article-title":"Dietary polyphenolsmay affect DNA methylation","volume":"137","author":"Fang","year":"2007","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/bs.mcb.2025.02.021_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2025.02.021_bib42","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.str.2011.06.011","article-title":"Structural basis of substrate methylation and inhibition of SMYD2","volume":"19","author":"Ferguson","year":"2011","journal-title":"Structure"},{"key":"10.1016\/bs.mcb.2025.02.021_bib43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bjh.12332","article-title":"A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy","volume":"161","author":"Finazzi","year":"2013","journal-title":"British Journal of Haematology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: Mining complete cancer genomes in the catalogue of somatic mutations in cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"Fraga","year":"2005","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib46","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1158\/0008-5472.CAN-08-3114","article-title":"The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2","volume":"69","author":"Friedman","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib47","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.M210256200","article-title":"The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation","volume":"278","author":"Fuks","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng886","article-title":"Role for DNA methylation in the control of cell type specific maspin expression","volume":"31","author":"Futscher","year":"2002","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.51","article-title":"Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo","volume":"4","author":"Gajer","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1016\/bs.mcb.2025.02.021_bib50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-14-2820","article-title":"A phase I study of CUDC-101, a multitarget inhibitor of HDACs, EGFR, and HER2, in combinationwith chemoradiation in patientswith head and neck squamous cell carcinoma","volume":"21","author":"Galloway","year":"2015","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib51","article-title":"A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.021_bib52","doi-asserted-by":"crossref","first-page":"11789","DOI":"10.1158\/0008-5472.CAN-07-2721","article-title":"Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation","volume":"67","author":"Germaniuk-Kurowska","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2011.11.001","article-title":"6- Alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site","volume":"47","author":"Ghizzoni","year":"2012","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098176","article-title":"3-Deazaneplanocin a (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells","volume":"9","author":"Girard","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.021_bib55","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.18632\/oncotarget.1909","article-title":"Anti-neoplastic properties of hydralazine in prostate cancer","volume":"5","author":"Gra\u00e7a","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/bs.mcb.2025.02.021_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-110","article-title":"Promoter methylation and expression of TIMP3 gene in gastric cancer","volume":"8","author":"Guan","year":"2013","journal-title":"Diagnostic Pathology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/pcan.2016.21","article-title":"Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration-and docetaxel-resistant prostate cancer cells","author":"Gupta","year":"2016","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"10.1016\/bs.mcb.2025.02.021_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: Implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-13-29","article-title":"Histone acetyltransferase- deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth","volume":"13","author":"Haery","year":"2014","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib60","doi-asserted-by":"crossref","first-page":"17063","DOI":"10.1074\/jbc.M309002200","article-title":"Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells","volume":"279","author":"Hattori","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: Small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib62","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/j.1460-2075.1988.tb02956.x","article-title":"A direct link between core histone acetylation and transcriptionally active chromatin","volume":"7","author":"Hebbes","year":"1988","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2025.02.021_bib63","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers","volume":"55","author":"Herman","year":"1995","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib64","first-page":"1","article-title":"Deaths: Leading causes for 2009","volume":"61","author":"Heron","year":"2012","journal-title":"National Vital Statistics Reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System"},{"key":"10.1016\/bs.mcb.2025.02.021_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.molonc.2012.07.004","article-title":"The role of histone demethylases in cancer therapy","volume":"6","author":"Hoffmann","year":"2012","journal-title":"Molecular Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib66","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/1078-0432.CCR-04-2406","article-title":"Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine","volume":"11","author":"Holleran","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib67","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1039\/c3sc51122g","article-title":"5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation","volume":"4","author":"Hopkinson","year":"2013","journal-title":"Chemical Science"},{"key":"10.1016\/bs.mcb.2025.02.021_bib68","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2007.09.041","article-title":"RNF8transduces the DNA-damage signal via histone ubiquitylation and checkpointprotein assembly","volume":"131","author":"Huen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060022","article-title":"A novel CpG island set identifies tissuespecific methylation at developmental gene loci","volume":"6","author":"Illingworth","year":"2008","journal-title":"PLoS Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib70","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1470-2045(15)00038-8","article-title":"Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study","volume":"16","author":"Issa","year":"2015","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib71","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Iyer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2025.02.021_bib72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2025.02.021_bib73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1947601912448068","article-title":"Current progress on understanding microRNAs in glioblastoma multiforme","volume":"3","author":"Karsy","year":"2012","journal-title":"Genes & Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib75","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1093\/emboj\/cdf401","article-title":"Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases","volume":"21","author":"Kim","year":"2002","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2025.02.021_bib76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.mcb.2025.02.021_bib77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.114.214577","article-title":"DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLLrearranged leukemia cells","volume":"350","author":"Klaus","year":"2014","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib78","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","article-title":"Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma","volume":"13","author":"Knutson","year":"2014","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib79","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib80","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib81","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib82","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bmc.2009.11.050","article-title":"Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation","volume":"18","author":"Kuck","year":"2010","journal-title":"Bioorganic & medicinal chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib83","series-title":"Research anthology on advancements in women\u2019s health and reproductive rights","first-page":"230","article-title":"Epigenetic regulation of breast cancer","author":"Kumar","year":"2022"},{"issue":"2","key":"10.1016\/bs.mcb.2025.02.021_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317692258","article-title":"Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line","volume":"39","author":"Kumar","year":"2017","journal-title":"Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"10.1016\/bs.mcb.2025.02.021_bib85","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13277-015-3781-8","article-title":"Phenylbutyrate\u2014a pan-HDAC inhibitor\u2014suppresses proliferation of glioblastoma LN-229 cell line","volume":"37","author":"Kusaczuk","year":"2016","journal-title":"Tumor Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jmcb\/mjq053","article-title":"Epigenetic changes of DNA repair genes in cancer","volume":"3","author":"Lahtz","year":"2011","journal-title":"Journal of Molecular Cell Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib87","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/onc.2009.361","article-title":"Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition","volume":"29","author":"Lakshmikuttyamma","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/bs.mcb.2025.02.021_bib88","doi-asserted-by":"crossref","first-page":"40749","DOI":"10.1074\/jbc.M505593200","article-title":"Procainamide is a specific inhibitor of DNA methyltransferase 1","volume":"280","author":"Lee","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib89","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0960-9822(03)00432-9","article-title":"Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin","volume":"13","author":"Lehnertz","year":"2003","journal-title":"Current Biology: CB"},{"key":"10.1016\/bs.mcb.2025.02.021_bib90","first-page":"59","article-title":"Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer","volume":"1","author":"Leick","year":"2012","journal-title":"American Journal of Stem Cells"},{"key":"10.1016\/bs.mcb.2025.02.021_bib91","first-page":"1","article-title":"MiR-124 acts as a tumor suppressor in glioblastoma via the inhibition of signal transducer and activator of transcription 3","author":"Li","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbrc.2003.12.079","article-title":"Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer","volume":"314","author":"Li","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.mcb.2025.02.021_bib93","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1073\/pnas.0401866101","article-title":"Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome","volume":"101","author":"Liang","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.021_bib94","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/cgt.2012.70","article-title":"Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells","volume":"19","author":"Lin","year":"2012","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.mcb.2025.02.021_bib95","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1242\/dev.007047","article-title":"Zeb1 links epithelialmesenchymal transition and cellular senescence","volume":"135","author":"Liu","year":"2008","journal-title":"Development"},{"key":"10.1016\/bs.mcb.2025.02.021_bib96","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 A resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2025.02.021_bib97","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1006150506789","article-title":"Urokinase induces receptor mediated brain tumor cell migration and invasion","volume":"40","author":"MacDonald","year":"1998","journal-title":"Journal of Neuro-oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib98","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/acs.jmedchem.5b01758","article-title":"Recent progress in histone demethylase inhibitors","volume":"59","author":"McAllister","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib99","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2012.10.025","article-title":"Histone acetylation regulates intracellular pH","volume":"49","author":"McBrian","year":"2013","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib100","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/leu.2014.169","article-title":"The emerging roles of DOT1L in leukemia and normal development","volume":"28","author":"McLean","year":"2014","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U. K"},{"key":"10.1016\/bs.mcb.2025.02.021_bib101","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature06008","article-title":"Genome-wide maps of chromatin state in pluripotent and lineage-committed cells","volume":"448","author":"Mikkelsen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2025.02.021_bib102","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","article-title":"A pilot phase II study of valproic acid for treatment of lowgrade neuroendocrine carcinoma","volume":"16","author":"Mohammed","year":"2011","journal-title":"The Oncologist"},{"key":"10.1016\/bs.mcb.2025.02.021_bib103","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10637-015-0206-x","article-title":"Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia","volume":"33","author":"Morschhauser","year":"2015","journal-title":"Investigational New Drugs"},{"key":"10.1016\/bs.mcb.2025.02.021_bib104","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","article-title":"Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/bs.mcb.2025.02.021_bib105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpGbinding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2025.02.021_bib106","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1074\/jbc.M114.626861","article-title":"LLY-507, a cell-active, potent, and selective inhibitor of protein-lysine methyltransferase SMYD2","volume":"290","author":"Nguyen","year":"2015","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib107","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tig.2004.02.007","article-title":"Phosphorylation of histone H3: A balancing act between chromosome condensation and transcriptional activation","volume":"20","author":"Nowak","year":"2004","journal-title":"Trends in Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib108","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1172\/JCI31771","article-title":"Review series personal perspective discovery of the Philadelphia chromosome: A personal perspective","volume":"117","author":"Nowell","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.mcb.2025.02.021_bib109","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/bs.mcb.2025.02.021_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131716","article-title":"The histonemethyltransferase inhibitor A-366 uncovers a role for G9a\/GLP in the epigenetics of leukemia","volume":"10","author":"Pappano","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.021_bib111","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s13277-011-0215-0","article-title":"The association between non-Hodgkin lymphoma and methylation of p73","volume":"32","author":"Pei","year":"2011","journal-title":"Tumor Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib112","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1987636","article-title":"Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region","volume":"251","author":"Prendergast","year":"1991","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2025.02.021_bib113","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/cb500018s","article-title":"A selective phenelzine analogue inhibitor of histone demethylase LSD1","volume":"9","author":"Prusevich","year":"2014","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib114","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.leukres.2012.03.003","article-title":"Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosis","volume":"36","author":"Quint\u00e1s-Cardama","year":"2012","journal-title":"Leukemia Research"},{"issue":"1","key":"10.1016\/bs.mcb.2025.02.021_bib115","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1777-9","article-title":"Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation","volume":"15","author":"Rauscher","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib116","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cellsig.2011.02.003","article-title":"DNA hypermethylation as a chemotherapy target","volume":"23","author":"Ren","year":"2011","journal-title":"Cellular Signalling"},{"key":"10.1016\/bs.mcb.2025.02.021_bib117","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1101\/gad.275529.115","article-title":"Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer","volume":"30","author":"Reynoird","year":"2016","journal-title":"Genes & Development"},{"key":"10.1016\/bs.mcb.2025.02.021_bib118","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1242\/dev.02723","article-title":"Polycomb\/trithorax response elements and epigenetic memory of cell identity","volume":"134","author":"Ringrose","year":"2007","journal-title":"Development"},{"key":"10.1016\/bs.mcb.2025.02.021_bib119","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1158\/0008-5472.CAN-06-0293","article-title":"Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers","volume":"66","author":"Rodriguez","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib120","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1021\/jm800936s","article-title":"Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases","volume":"51","author":"Rose","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/bs.mcb.2025.02.021_bib121","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/epi.10.2","article-title":"Hypomethylation of repeated DNA sequences in cancer","volume":"2","author":"Ross","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib122","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35106108","article-title":"Chromosome translocations: Dangerous liaisons revisited","volume":"1","author":"Rowley","year":"2001","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib123","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","article-title":"Epigenetic activation of tumor suppressor micro-RNAs in human cancer cells","volume":"5","author":"Saito","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/bs.mcb.2025.02.021_bib124","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CBI20110649","article-title":"DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling","volume":"36","author":"Savickiene","year":"2012","journal-title":"Cell Biology International"},{"key":"10.1016\/bs.mcb.2025.02.021_bib125","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1021\/jm100217a","article-title":"(Bis) urea and (bis) thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators","volume":"53","author":"Sharma","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg2218","article-title":"Histone lysine demethylases: Emerging roles in development, physiology and disease","volume":"8","author":"Shi","year":"2007","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib127","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/hmg\/10.13.1413","article-title":"Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies","volume":"10","author":"Smiraglia","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib128","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2165\/11596690-000000000-00000","article-title":"Epigenetic-based therapies in cancer: progress to date","volume":"71","author":"Song","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/bs.mcb.2025.02.021_bib129","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-05-0135","article-title":"Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity","volume":"4","author":"Stimson","year":"2005","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fonc.2014.00080","article-title":"DNA methyltransferases: A novel target for prevention and therapy","volume":"4","author":"Subramaniam","year":"2014","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib132","first-page":"1","article-title":"MiR-200 suppresses metastases of colorectal cancer through ZEB1","author":"Sun","year":"2015","journal-title":"Tumor Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib133","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","article-title":"Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation","volume":"580","author":"Sun","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.mcb.2025.02.021_bib134","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: Provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acsmedchemlett.5b00124","article-title":"Discovery of A-893, a new cell-active benzoxazinone inhibitor of lysine methyltransferase SMYD2","volume":"6","author":"Sweis","year":"2015","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/bs.mcb.2025.02.021_bib136","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bcp.2004.04.030","article-title":"DNA methylation and breast cancer","volume":"68","author":"Szyf","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib137","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/emboj.2008.192","article-title":"G9a\/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription","volume":"27","author":"Tachibana","year":"2008","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.mcb.2025.02.021_bib138","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1073\/pnas.052410099","article-title":"Comprehensive analysis of CpG islands in human chromosomes 21 and 22","volume":"99","author":"Takai","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2025.02.021_bib139","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/acs.jmedchem.5b01732","article-title":"Identification of cyproheptadine as an inhibitor of SET domain containing lysine methyltransferase 7\/9 (Set7\/9) that regulates estrogen-dependent transcription","volume":"59","author":"Takemoto","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib140","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbagrm.2014.05.009","article-title":"Targeting histone lysine demethylases\u2014progress, challenges, and the future","volume":"1839","author":"Thinnes","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"key":"10.1016\/bs.mcb.2025.02.021_bib141","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","article-title":"Histone acetylation and disease","volume":"58","author":"Timmermann","year":"2001","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/bs.mcb.2025.02.021_bib142","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2016.02.049","article-title":"Inhibition of DNAmethyltransferase or histone deacetylase protects retinal pigment epithelial cells from DNA damage induced by oxidative stress by the stimulation of antioxidant enzymes","volume":"776","author":"Tokarz","year":"2016","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib143","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nchembio.599","article-title":"A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells","volume":"7","author":"Vedadi","year":"2011","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib144","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-0312","article-title":"A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors","volume":"19","author":"Venugopal","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib145","first-page":"4984","article-title":"Procaine is a DNA demethylating agent with growth-inhibitory effects in human cancer cells","volume":"63","author":"Villar-Garea","year":"2003","journal-title":"Cancer Research"},{"issue":"6127","key":"10.1016\/bs.mcb.2025.02.021_bib146","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/bs.mcb.2025.02.021_bib147","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"Volkel","year":"2015","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/bs.mcb.2025.02.021_bib148","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nbt.2300","article-title":"New lysine methyltransferase drug targets in cancer","volume":"30","author":"Wagner","year":"2012","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib149","first-page":"4","article-title":"Resminostat in relapsed or refractory Hodgkin lymphoma: Initial results of the SAPHIRE phase II trial with a novel oral histone deacetylase (HDAC) inhibitor","author":"Walewski","year":"2010","journal-title":"Proceedings of the 52nd ASH Annual Meeting and Exposition, Orlando, FL, USA"},{"key":"10.1016\/bs.mcb.2025.02.021_bib150","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/bioinformatics\/bth059","article-title":"An evaluation of new criteria for CpG islands in the human genome as gene markers","volume":"20","author":"Wang","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib151","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib152","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng.268","article-title":"The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation","volume":"41","author":"Wang","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib153","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbrc.2015.09.164","article-title":"Inhibition of LSD1 by pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo","volume":"467","author":"Wang","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.mcb.2025.02.021_bib154","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1101\/gad.2.9.1136","article-title":"Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter","volume":"2","author":"Watt","year":"1988","journal-title":"Genes & Development"},{"key":"10.1016\/bs.mcb.2025.02.021_bib155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.297","article-title":"Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells","volume":"41","author":"Wen","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib156","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/ijc.27555","article-title":"Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor","volume":"131","author":"Willmann","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.mcb.2025.02.021_bib157","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1200\/JCO.2011.38.9411","article-title":"Randomized phase II trial of erlotinibwith and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy","volume":"30","author":"Witta","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019027","article-title":"Epigenetic inactivation of the miR-124-1 in haematological malignancies","volume":"6","author":"Wong","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.mcb.2025.02.021_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066587","article-title":"The prognostic value of p16 hypermethylation in cancer: A meta-analysis","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS ONe"},{"key":"10.1016\/bs.mcb.2025.02.021_bib160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/me.2013-1293","article-title":"Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b","volume":"28","author":"Yang","year":"2014","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib161","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000375503","article-title":"Targeting DNA methylation with green tea catechins","volume":"95","author":"Yiannakopoulou","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib162","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(15)00584-7","article-title":"Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: An open-label, dose-escalation, phase 1 trial","volume":"17","author":"Younes","year":"2016","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib163","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.febslet.2012.06.049","article-title":"Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3","volume":"586","author":"Zeng","year":"2012","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.mcb.2025.02.021_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Developmental Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nsmb.1568","article-title":"PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing","volume":"16","author":"Zhao","year":"2009","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/bs.mcb.2025.02.021_bib166","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2174\/1568026616666160216154042","article-title":"Irreversible LSD1 inhibitors: Application of tranylcypromine and its derivatives in cancer treatment","volume":"16","author":"Zheng","year":"2016","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/bs.mcb.2025.02.021_bib167","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00726-011-1004-1","article-title":"Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells","volume":"42","author":"Zhu","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/bs.mcb.2025.02.021_bib168","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.febslet.2012.11.004","article-title":"MiR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6","volume":"587","author":"Zhu","year":"2013","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.mcb.2025.02.021_bib169","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-16-S7-S8","article-title":"Oncogenes and tumor suppressor genes: Comparative genomics and network perspectives","volume":"16","author":"Zhu","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.mcb.2025.02.021_bib170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-015-3338-y","article-title":"Hypermethylation of BRCA1 gene: Implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer","volume":"150","author":"Zhu","year":"2015","journal-title":"Breast Cancer Research and Treatment"}],"container-title":["Methods in Cell Biology","Advanced Cancer Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X25000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T15:43:24Z","timestamp":1763048604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X25000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443414435"],"references-count":170,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2025.02.021","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}